Follow Chr. Hansen A/S

Press releases View all 408 hits

Probiotics may provide relief for infants with colic, new study reveals

Probiotics may provide relief for infants with colic, new study reveals

Press releases   •   Dec 04, 2019 10:01 UTC

Up to one in four infants globally suffer from excessive crying and fussing – often called colic. A new study shows that the BB-12® probiotic strain may help reduce crying duration and the number of crying episodes and bring relief to infants and their parents

Probiotics may help preterm infants

Probiotics may help preterm infants

Press releases   •   Nov 28, 2019 08:51 UTC

A new three-strain probiotic blend from Chr. Hansen can help support the health and development of intestines in preterm babies and has been shown to reduce risk of Necrotizing enterocolitis by 50%

Chr. Hansen’s Head of Sustainability recognized as Meaningful Business 100 Leader

Chr. Hansen’s Head of Sustainability recognized as Meaningful Business 100 Leader

Press releases   •   Nov 06, 2019 12:09 UTC

Global platform brings together the top 100 business leaders who are combining profit and purpose to help achieve the UN Sustainable Development Goals

Chr. Hansen reaches 7% organic growth in 2018/19

Chr. Hansen reaches 7% organic growth in 2018/19

Press releases   •   Oct 10, 2019 06:28 UTC

Despite more challenging growth conditions Chr. Hansen delivers a strong EBIT margin and a healthy cash flow, while also making significant progress on key strategic priorities

News 1 hit

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

News   •   Aug 29, 2019 09:16 UTC

​Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce today that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint venture in the emerging market for live biotherapeutic products, which was originally announced in Company Announcement No. 04 on April 2, 2019.

Images View all 10 hits

Chr. Hansen probiotics

Chr. Hansen probiotics

License Creative Commons Attribution
Photographer / Source Chr. Hansen
Download
Size

11.1 MB • 4872 x 6496 px

Caelus logo

Caelus logo

License Creative Commons Attribution
Download
Size

113 KB • 1193 x 1224 px

World Beverage Innovation FeelGood Kefir
Chr. Hansne DVS® FRESCO® 1000NG

Chr. Hansne DVS® FRESCO® ...

License Creative Commons Attribution
Download
Size

5.18 MB • 3328 x 4992 px

Documents 4 hits

FeelGood Kefir brochure

FeelGood Kefir brochure

Documents   •   Nov 27, 2015 12:13 UTC

Chr. Hansen DVS® FRESCO® 1000NG

Chr. Hansen DVS® FRESCO® 1000NG

Documents   •   Oct 30, 2015 08:00 UTC

L. CASEI 431® Selected summaries

L. CASEI 431® Selected summaries

Documents   •   May 21, 2015 06:57 UTC

This binder provides you with summaries of selected publications on Lactobacillus paracasei subsp. paracasei L. casei 431®.

L. CASEI 431® Handout

L. CASEI 431® Handout

Documents   •   May 21, 2015 06:57 UTC

Chr. Hansen offers multiple application forms of one of our most clinically documented Probio-Tec® strains, Lactobacillus L. casei 431®.

Contacts View all 5 hits

  • Commercial Development Manager
  • DKtuJScvY@gfchxer-cshainnsxhenov.cfcomwe
  • +45 25 46 10 07

  • Regional Communications Partner
  • USzoALskNOaq@ckdhrji-hyxansiseyhn.lhcoqlmjc
  • +14146075862

  • Head of Investor Relations
  • dkprmakmrirc@celhrcn-hboantlseudn.cfcozbmcu
  • +4553392250
Head of Investor Relations

  • Regional Communications Partner
  • APAC
  • SGcnCHhtONpw@chdhrsv-hsuanjsseuln.tvcoqmm lo
  • +6597433100